GlaxoSmithKline (Nimenrix And Mencevax) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
GlaxoSmithKline (Nimenrix And Mencevax) General Information
Description
Two quadrivalent meningitis ACWY vaccines of GlaxoSmithKline.. These vaccines are a single-dose meningococcal vaccines used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
GlaxoSmithKline (Nimenrix And Mencevax) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GlaxoSmithKline (Nimenrix And Mencevax) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|